8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
2021 / Narrative review
This review investigated whether a plant-based diet could reduce the burden of long-COVID symptoms, such as fatigue, sleep difficulties, anxiety, depression, and musculoskeletal pain. While clinical trials examining plant-based nutrition in COVID-19 prevention and management are currently limited, pre-pandemic evidence suggests plant-based diets benefit conditions such as anxiety, depression, sleep disorders, and musculoskeletal pain. By reducing the intake of pro-inflammatory mediators, adopting a plant-based diet may help address prolonged systemic inflammation associated with long-COVID.
Storz MA Curr Nutr Rep, 2021. PMID 34506003
2021 / Narrative review
This review examines how ageing impacts NAD+ metabolism and describes strategies to counter its age-dependent decline. NAD+ serves as a vital coenzyme and signalling molecule consumed by enzymes like PARPs, SARM1, sirtuins, and CD38. Tissue NAD+ levels decrease during ageing due to an imbalance between synthesis and consumption, and this decline has been linked to metabolic diseases and cognitive decline. Therapeutic augmentation of NAD+ levels may halt or reverse the progression of certain age-related conditions.
Strømland Ø, Diab J, Ferrario E, et al. Mech Ageing Dev, 2021. PMID 34509469
2021 / Narrative review
This review summarizes preclinical and clinical evidence on the biological activity, safety, and potential side effects of NAD+ precursors, focusing on nicotinamide riboside (NR), nicotinamide mononucleotide (NMN), and dihydronicotinamide riboside (NRH). Emerging data indicate an age-dependent reduction in cellular NAD+. In preclinical models, replenishing NAD+ extends healthspan or lifespan and mitigates conditions such as premature aging and neurodegenerative diseases.
Reiten OK, Wilvang MA, Mitchell SJ, et al. Mech Ageing Dev, 2021. PMID 34517020
2020 / Review of prospective longitudinal cohort studies
This review examined environmental, lifestyle, dietary, comorbid, and pharmacological factors investigated in longitudinal cohort studies regarding the development, progression, and subtypes of Parkinson's disease (PD). Findings indicate that only 11 factors possess sufficient epidemiological evidence and biological plausibility, with pesticides, dairy products, and β2-adrenoreceptor antagonists identified as risk factors. Protective factors identified were smoking, caffeine and tea intake, physical activity, gout, vitamin E intake, NSAIDs, and β2-adrenoreceptor agonists. Caffeine intake and physical activity also appeared to slow PD progression, while modifiable risk factors for PD subtypes remain almost unknown.
Shows an association, not proof of cause and effect.
Belvisi D, Pellicciari R, Fabbrini G, et al. Neurobiol Dis, 2020. PMID 31706021
2020 / Narrative review
This narrative review evaluated evidence regarding the effectiveness and potential mechanisms of yoga as a therapy for IBS. Evidence from randomized controlled trials identified yoga as more effective than pharmacological treatment and equally effective as dietary interventions or moderate-intensity walking. Improvements were observed in physical health outcomes (IBS symptom severity, gastric motility, autonomic and somatic symptom scores, and physical functioning) and mental health outcomes (depression, anxiety, gastrointestinal-specific anxiety, and quality of life). However, the evidence is of relatively low quality due to heterogeneity in study designs, interventions, and outcome measures.
D'Silva A, MacQueen G, Nasser Y, et al. Dig Dis Sci, 2020. PMID 31832970
2020 / Narrative review
This narrative review examined the implications of changing dietary patterns, specifically the rise of ultra-processed (NOVA-4) foods, on metabolic and neurobiological pathways related to eating disorders. The increased intake of sugars and food additives has metabolic consequences, including triggering insulin and glucose responses, stimulating appetite, and affecting endocrine pathways, neurobiology, and the microbiome. The authors propose integrating metabolic responses to modern highly processed foods into existing psychological models to improve eating disorder research and treatment outcomes.
Ayton A, Ibrahim A Nutr Rev, 2020. PMID 31846028
2020 / Narrative review
This review examines the physiological and nutritional roles of taurine, creatine, carnosine, anserine, and 4-hydroxyproline, noting they are highly abundant in beef and mostly absent or negligible in plant foods. The authors state that consuming 30 g of dry beef can meet the daily physiological needs of a healthy 70-kg adult for taurine and carnosine. These nutrients play roles in anti-oxidative and anti-inflammatory pathways and are reported to benefit metabolic, cardiovascular, immune, neurological, skin, and bone health.
NANO counterpoint →
Wu G Amino Acids, 2020. PMID 32072297
2020 / Narrative review
This narrative review summarizes scientific evidence on dementia prevention across three main strategies: targeting the body to protect the brain, compensatory interventions against brain aging, and lifespan health promotion such as physical activity, smoking cessation, and a healthy balanced diet. It examines biological mechanisms including neurodegeneration, brain resilience, vascular damage, neuroinflammation, and oxidative stress. The authors conclude that timely multidomain preventive actions are promising strategies to reduce dementia incidence worldwide, though a gap remains between epidemiological evidence and underlying biological mechanisms.
Grande G, Qiu C, Fratiglioni L Ageing Res Rev, 2020. PMID 32171784
2020 / Narrative review
This narrative review summarizes findings on resveratrol from epidemiological surveys, experimental studies, and clinical trials. The authors report that resveratrol exhibits antioxidant, anti-inflammatory, immunomodulatory, glucose and lipid regulatory, neuroprotective, and cardiovascular protective effects. Based on these mechanisms, it is noted to protect against diverse chronic conditions including cardiovascular diseases, cancer, liver diseases, obesity, diabetes, Alzheimer's disease, and Parkinson's disease.
Meng X, Zhou J, Zhao CN, et al. Foods, 2020. PMID 32183376
2020 / Narrative review
This review discusses the impact of nutrition on COVID-19 susceptibility and outcomes. Consumption of a Western diet rich in saturated fats, sugars, and refined carbohydrates contributes to obesity and type 2 diabetes, which may place individuals at higher risk for severe COVID-19 pathology and death. The authors note that a Western diet activates innate immunity, impairs adaptive immunity, and leads to chronic inflammation and compromised viral defenses, while post-infection neuroinflammation could increase risks for conditions like dementia.
Butler MJ, Barrientos RM Brain Behav Immun, 2020. PMID 32311498
2020 / Narrative review
This review examines evidence on sodium intake and target organ damage in hypertension. The authors report that current global sodium consumption exceeds safe levels and that sodium intake is directly related to increased blood pressure and independently to cardiac mass enlargement. High sodium intake may also induce renal damage progression in both hypertensive and normotensive individuals and play an adverse role in cerebrovascular disease.
Nista F, Gatto F, Albertelli M, et al. Int J Environ Res Public Health, 2020. PMID 32325839
2020 / Methodological review / discussion
This article discusses cause-and-effect relationships and the possibility of reverse causation. Specifically, it uses physical inactivity and dementia as an example, noting inactivity may predispose to dementia via cardiometabolic mechanisms, but may also stem from an ongoing dementia prodrome slowing patients down before diagnosis. It reviews how reverse causation was assessed in a recent individual participant data meta-analysis and notes other interpretations are possible when findings suggest reverse causation.
Shows an association, not proof of cause and effect.
Andrade C Indian J Psychol Med, 2020. PMID 32346267
2020 / Narrative review of epidemiological, animal, and in vitro studies
Authors reviewed human exposure levels, animal experiments, in vitro studies, and 23 epidemiological studies published since 2012 regarding fluoride and developmental neurotoxicity. The margin of exposure (MoE) between animal NOAELs and human adequate intake (50 µg/kg b.w./day) ranged from 50 to 210, remaining at least 10 even for unusually high exposures. While 21 of 23 recent epidemiological studies reported an association between high fluoride exposure and reduced intelligence, the authors noted potential deficiencies in these studies, particularly regarding confounding factors like socioeconomic status and maternal intelligence. Based on the totality of evidence, the review concluded that current exposure levels in Europe do not support classifying fluoride as a human developmental neurotoxicant.
Guth S, Hüser S, Roth A, et al. Arch Toxicol, 2020. PMID 32382957
2020 / Narrative review
This review summarizes data on nicotinamide riboside (NR), an NAD+ precursor studied for its health benefits mediated through elevated NAD+ content. Evidence from animal and human studies indicates effectiveness in treating cardiovascular, neurodegenerative, and metabolic disorders, as well as emerging potential against pathogens such as SARS-CoV-2. The review also discusses challenges related to NR's bioavailability and safety, and compares it to other NAD+ precursors.
Mehmel M, Jovanović N, Spitz U Nutrients, 2020. PMID 32486488
2020 / Narrative review with systematic search
This narrative review systematically searched and appraised studies examining associations between ultra-processed food (UPF) intake and health outcomes in healthy participants. Out of 43 reviewed studies, 37 found UPF exposure was associated with at least one adverse health outcome. In adults, reported associations included overweight, obesity, cardio-metabolic risks, cancer, type-2 diabetes, cardiovascular diseases, irritable bowel syndrome, depression, frailty conditions, and all-cause mortality; in children and adolescents, outcomes included cardio-metabolic risks and asthma. No study reported an association between UPF and beneficial health outcomes, and the authors note that most findings were derived from observational studies.
Shows an association, not proof of cause and effect.
Elizabeth L, Machado P, Zinöcker M, et al. Nutrients, 2020. PMID 32630022
2020 / Narrative review
This review examines human evidence regarding the relationship between sleep and Alzheimer's disease (AD). Sleep disturbances have been associated with increased future risk of AD. The review notes a hypothesized bi-directional relationship between sleep and AD, exploring sleep disturbances as markers for AD pathology, mechanisms mediating increased risk, and the therapeutic potential and challenges of treating sleep disturbances to prevent or delay AD onset.
Shows an association, not proof of cause and effect.
Lucey BP Neurobiol Dis, 2020. PMID 32738506
2020 / Narrative review
This review examines the impact of glyphosate and glyphosate-based herbicides on mammal and fish health, with a particular focus on immunity. In mammals, including humans, glyphosate exhibits cytotoxic and genotoxic effects, induces inflammation, and impairs lymphocyte functions and interactions between microorganisms and the immune system. Evidence also highlights increased oxidative stress, estrogen pathway disruption, impaired cerebral functions, and alleged correlations with certain cancers. The authors note an absence of clear regulatory consensus and emphasize the need for further studies to clarify risks.
Peillex C, Pelletier M J Immunotoxicol, 2020. PMID 32897110
2020 / Critical narrative review
This review critically evaluated papers reporting the effects of ingesting melatonin-rich food on plasma or saliva melatonin or its urinary metabolite. The author noted that many published studies are compromised by poor experimental design, faulty assay methodologies, and uncritical evaluation of results. The review concluded that it is wishful thinking to expect that the amount of melatonin present in 'melatonin-rich' foods will impact sleep or have any other physiological effect.
Kennaway DJ Food Funct, 2020. PMID 33170194
2019 / Narrative review
This review explores the multifactorial relationship between mastication and cognition, focusing on dementia. While animal studies suggest that decreased masticatory activity leads to memory loss and neuronal degeneration, a cause-and-effect relationship has not been proven in humans. Multiple factors likely play a role in this link, including self-care, nutrition, stress, and pain.
Shows an association, not proof of cause and effect.
Weijenberg RAF, Delwel S, Ho BV, et al. Gerodontology, 2019. PMID 30480331
2019 / Review
This review evaluates strategies for migraine prophylaxis. Managing environmental, dietary, and behavioral triggers serves as a useful prevention strategy. Alongside pharmacologic and behavioral interventions, complementary treatments including petasites, feverfew, magnesium, and riboflavin are identified as probably effective for migraine prevention.
Ha H, Gonzalez A Am Fam Physician, 2019. PMID 30600979
2019 / Expert consensus and narrative review
The Asian Clinical Expert Group on Neurocognitive Disorders compiled evidence-based consensus recommendations on using Ginkgo biloba extract EGb 761® for neurocognitive disorders. The review reports that randomized trials and meta-analyses showed significant improvements in cognitive function, neuropsychiatric symptoms, activities of daily living, and quality of life versus placebo in mild-to-moderate dementia, as well as symptomatic improvement in mild cognitive impairment. Safety analyses indicated a positive risk-benefit profile, and trials and meta-analyses did not support an increased bleeding risk. The Expert Group foresees an important role for EGb 761® alone or as add-on therapy, aligned with local clinical guidelines.
Kandiah N, Ong PA, Yuda T, et al. CNS Neurosci Ther, 2019. PMID 30648358
2019 / Narrative review of clinical trials
This review evaluates clinical evidence on the polyphenolic nutraceutical resveratrol, whose efficacy, safety, and pharmacokinetics have been documented in over 244 clinical trials with 27 ongoing. Resveratrol is reported to potentially improve therapeutic outcomes in conditions such as diabetes mellitus, obesity, cancers, metabolic syndrome, hypertension, Alzheimer's disease, cardiovascular diseases, and kidney diseases. It is reported to be safe at doses up to 5 g/day alone or in combination therapy. However, its therapeutic use is limited by rapid metabolism and poor bioavailability, though a micronized formulation (SRT501) shows promise.
Singh AP, Singh R, Verma SS, et al. Med Res Rev, 2019. PMID 30741437
2019 / Narrative review
This review examines the evidence surrounding creatine supplementation in various pathological and paraphysiological conditions. Evidence indicates it improves muscular strength and well-being in muscular dystrophies, assists in hereditary synthesis disorders, statin myopathy, and treatment-resistant depression in women. Creatine supplementation also increases muscular and neuropsychological performance in vegetarians and vegans, and shows effectiveness in sarcopenia, muscular atrophy, and states of brain energy shortage. Randomized, placebo-controlled trials show it is safe up to 20 g/d, with a possible caveat in individuals with kidney disease.
Balestrino M, Adriano E Med Res Rev, 2019. PMID 31012130
2019 / Narrative review
This review evaluates the blood pressure-independent physiological effects of dietary salt and controversies surrounding lower salt intakes and cardiovascular outcomes. High dietary salt has been shown to adversely affect the vasculature, heart, kidneys, skin, brain, and bone, mediated commonly by heightened inflammation and oxidative stress. The review also addresses the role of background diet in modulating the effects of salt.
Robinson AT, Edwards DG, Farquhar WB Curr Hypertens Rep, 2019. PMID 31025198